Tag: drug formulation market research

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Large Is the Drug Formulation Market Expected to Be in 2029?

The size of the drug formulation market has seen significant growth in the past few years. It is anticipated that the value of the market will increase from $1908.89 billion in 2024 to $2045.31 billion in 2025 with a compound annual growth rate (CAGR) of 7.1%. This rise during the historic period is due to factors like biopharmaceutical innovation, the development of patient-focused drugs, the advent of personalized medicine, regulatory backing for orphan drugs, and heightened investment in research and development.

In the coming years, the drug formulation market size is predicted to witness significant growth. The market is anticipated to reach “$2894.29 billion in 2029 with a compound annual growth rate (CAGR) of 9.1%. This expected growth in the forecast period is due to advancements in areas like 3d printing, emphasis on paediatric formulations, biological drug delivery systems, the use of green chemistry in formulation, and the incorporation of artificial intelligence (AI). The major trends identified for this forecast period include the dominance of biopharmaceuticals and biologics, the presence of advanced drug delivery systems, personalised medicine and individualised formulations, the integration of nanotechnology, and lifecycle management and reformulation strategies.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9900&type=smp

What Are The Contributors To Demand In The Drug Formulation Market?

The escalating occurrence of long-term ailments is predicted to boost the expansion of the drug formulation industry. Chronic illnesses, defined as diseases that persist for at least a year and necessitate continuous medical care or impact daily life activities, could see a reduction in prevalence through drug formulation. This technique leverages various drug delivery methods to enhance therapeutic efficiency and lower adverse impacts by influencing medicine absorption, distribution, metabolism, and excretion. For example, a report from the National Institutes of Health (NIH), a United States-based biomedical research organization, stated in September 2022 that by 2023, the count of individuals over 50 years old suffering from at least one chronic disease in the US is anticipated to increase by 99.5%, jumping from 71.52 million in 2020 to 142.66 million in 2050. Moreover, the population with multimorbidity is speculated to surge by 91.16% from 7.8304 million in 2020 to 14.968 million in 2050. Ergo, the growing incidence of chronic diseases is fueling the advancement of the drug formulation market.

What Segmentation Categories Are Included In The Drug Formulation Market Analysis?

The drug formulation market covered in this report is segmented –

1) By Dosage Form: Oral formulations, Parenteral Formulations, Topical Formulations, Inhalation Formulations

2) By Formulation: Tablets, Capsules, Injectable, Sprays, Suspensions, Powders, Other Formulations

3) By Therapy Area: Cardiovascular Diseases (CVDs), Pain, Diabetes, Cancer, Respiratory Diseases, Other Diseases

4) By End-User: Big Pharma, Small And Medium Pharma, Biotech Companies

Subsegments:

1) By Oral Formulations: Tablets, Capsules, Powders, Liquids Or Solutions

2) By Parenteral Formulations: Injectables, Implants, Infusions

3) By Topical Formulations: Creams, Ointments, Gels, Transdermal Patches

4) By Inhalation Formulations: Metered-Dose Inhalers (MDIs), Dry Powder Inhalers (DPIs), Nebulizers

What Trends Are Currently Influencing Growth In The Drug Formulation Market?

Technological evolution is becoming an increasingly key trend in the drug formulation market. Industry leaders in the drug formulation market are focusing their efforts on developing and introducing cutting-edge technologies to solidify their market position. For example, in June 2022, U.S. pharmaceutical company Merck & Co., Inc. unveiled the Merck Digital Sciences Studio (MDSS), to facilitate the creation of groundbreaking technology for drug research and development. Merck leverages Azure Cloud’s strong computational abilities and the expertise of Merck’s research and clinical team to collaboratively expedite and assume control of new and innovative digital technologies. MDSS represents a partnership between Merck and the New Jersey Innovation Institute (NJII), a U.S. company under the ownership of the New Jersey Institute of Technology. The project has received funding from the Merck Global Health Innovation Fund, Northpond Ventures, and McKesson Ventures, whereas Microsoft will be contributing with technology support for start-ups.

Who Are The Top-Ranked Companies In The Drug Formulation Market Today?

Major companies operating in the drug formulation market include AstraZeneca PLC, The Bristol-Myers Squibb Company, Eli Lilly and Company, Gilead Sciences Inc., Merck & Co. Inc., Novartis AG, Pfizer Inc., AbbVie Inc., C.H. Boehringer Sohn AG & Co. KG, F. Hoffmann-La Roche AG, Johnson & Johnson, Bayer AG, Teva Pharmaceutical Industries Ltd., Sanofi S.A., GlaxoSmithKline plc, Novo Nordisk A/S, Amgen Inc., Viatris Inc., Sandoz International GmbH, Takeda Pharmaceutical Company Limited, Sun Pharmaceutical Industries Ltd., Dr. Reddy’s Laboratories Ltd., Cipla Ltd., Lupin Limited, Torrent Pharmaceuticals Limited, Jubilant Life Sciences Limited, Cadila Healthcare Limited, Glenmark Pharmaceuticals Ltd., Wockhardt Ltd., Hikma Pharmaceuticals plc

Get The Full Report Here:

https://www.thebusinessresearchcompany.com/report/drug-formulation-global-market-report

How Is Drug Formulation Market Adoption Varying Across Different Regions And Sectors?

North America was the largest region in the drug formulation market in 2024. Asia-Pacific is expected to be the fastest-growing region in the drug formulation market report during the forecast period. The regions covered in the drug formulation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=9900&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Discover trends, market shifts, and competitive outlooks for the drug formulation industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

How Fast Is The Drug Formulation Market Expected to Grow Between 2025 And 2029?

The market size for drug formulation has seen significant growth in the past few years. The market is projected to expand from $1908.89 billion in 2024 to $2064.68 billion in 2025, growing at a compound annual growth rate (CAGR) of 8.2%. The growth observed during the historical period can be credited to several factors, including innovation in biopharmaceuticals, the development of drugs focused on patient needs, personalized medicine, regulatory backing for orphan drugs, and a rise in R&D investment.

The pharmaceutical formulation industry is predicted to experience significant expansion in the forth coming years, reaching a market value of $2948.64 billion by 2029, with a compound annual growth rate (CAGR) of 9.3%. This anticipated growth in the forecast period can be linked to breakthroughs in 3D printing technology, concentration on pediatric formulations, biological drug distribution methods, the use of greener chemistry in formulation, and the incorporation of artificial intelligence (AI). Future trends estimated for this forecast period are the dominance of biopharmaceuticals and biologics, advanced drug dispensation systems, personalised medications and unique formulations, the fusion of nanotechnology, life cycle management and reformulation tactics.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9900&type=smp

How Are Key Drivers in the Industry Acting as Catalysts for the Growth of the Drug Formulation Market?

The increase in chronic illnesses is predicted to spur the expansion of the drug formulation market. Chronic diseases refer to conditions that persist for at least a year or more, necessitating continued medical care or limiting daily activities, or both. Drug formulation has the capability to decrease the occurrence of these chronic diseases by utilizing various drug delivery methods to enhance therapeutic effectiveness, while reducing negative side effects by impacting medication absorption, distribution, metabolism, and elimination. For example, the National Institutes of Health (NIH), a biomedical research organization based in the US, released a report in September 2022 that projects a 99.5% increase, from 71.52 million in 2020 to 142.66 million in 2050, in the number of people aged 50 and older with at least one chronic disease in the United States in 2023. The number of individuals suffering from multiple chronic illnesses is also expected to surge by 91.16%, from 7.8304 million in 2020 to 14.968 million in 2050. Thus, the escalating prevalence of chronic diseases is fuelling the expansion of the drug formulation market.

Which Segments in the Drug Formulation Offer the Most Growth?

The drug formulation market covered in this report is segmented –

1) By Dosage Form: Oral formulations, Parenteral Formulations, Topical Formulations, Inhalation Formulations

2) By Formulation: Tablets, Capsules, Injectable, Sprays, Suspensions, Powders, Other Formulations

3) By Therapy Area: Cardiovascular Diseases (CVDs), Pain, Diabetes, Cancer, Respiratory Diseases, Other Diseases

4) By End-User: Big Pharma, Small And Medium Pharma, Biotech Companies

Subsegments:

1) By Oral Formulations: Tablets, Capsules, Powders, Liquids Or Solutions

2) By Parenteral Formulations: Injectables, Implants, Infusions

3) By Topical Formulations: Creams, Ointments, Gels, Transdermal Patches

4) By Inhalation Formulations: Metered-Dose Inhalers (MDIs), Dry Powder Inhalers (DPIs), Nebulizers

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=9900&type=smp

What Are the Fastest-Growing Geographies in the Drug Formulation Market?

North America was the largest region in the drug formulation market in 2024. Asia-Pacific is expected to be the fastest-growing region in the drug formulation market report during the forecast period. The regions covered in the drug formulation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

What Are the Current Market Growth and Trends in the Drug Formulation Industry?

The emergence of innovative technologies is a prominent trend being observed in the drug formulation sector. Top-notch enterprises operating within this market are engaged in focusing their efforts towards the implementation of breakthrough technologies to consolidate their market stand. For instance, Merck & Co., Inc., a pharmaceutical firm based in the US, unveiled the Merck Digital Sciences Studio (MDSS) in June 2022, with the aim of leading the way in novel technologies for drug research and development. The Merck and Azure Cloud robust computing collaboration, alongside Merck’s expert discovery and clinical teams, are geared towards fast-tracking and taking on cutting-edge digital technologies. The project is a joint venture between Merck and the New Jersey Innovation Institute (NJII), an organisation based in the United States owned by the New Jersey Institute of Technology. The Merck Global Health Innovation Fund, Northpond Ventures, and McKesson Ventures have all financially backed the project. In addition, Microsoft is set to offer technological support to start-up companies.

View the full report here:

https://www.thebusinessresearchcompany.com/report/drug-formulation-global-market-report

What Are the Key Elements That Define the Drug Formulation Market?

Drug formulation is defined as the process of combining several chemical and biological ingredients, including the active medicine, to create a finished pharmaceutical product. It is used to be modify and optimize the drugs during the preclinical stage and initial research.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9900

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

How Are Key Drivers in the Industry Acting as Catalysts for the Growth of theDrug Formulation Market?

As chronic diseases become more commonplace, the drug formulation market is expected to expand. Chronic diseases, characterized as conditions that persist for a year or longer, necessitating ongoing medical care and often limiting daily activities, could potentially be mitigated through drug formulation. This is achieved by leveraging multiple drug delivery methods to bolster therapeutic efficacy and diminish side effects, thus influencing absorption, distribution, metabolism, and excretion of medication. The National Institutes of Health (NIH), a biomedical research agency based in the US, published a report in September 2022 stating that the number of individuals 50 years or older suffering from at least one chronic disease in the United States is forecasted to jump by 99.5%, from 71.52 million in 2020 to 142.66 million in 2050. The report also predicts an increase of 91.16% in people suffering from multimorbidity from 7.8304 million in 2020 to 14.968 million in 2050. Subsequently, the increasing incidence of chronic illnesses is stimulating the growth of the drug formulation market.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9900&type=smp

#What Growth Opportunities Will Drive the Drug Formulation Market’s CAGR Through 2034?

There has been a robust growth in the size of the drug formulation market in the past few years. Its growth is projected to continue from $1908.89 billion in 2024 to reach $2064.68 billion in 2025, with a compound annual growth rate (CAGR) of 8.2%. The notable growth during the historic period can be credited to factors such as biopharmaceutical innovation, a focus on patient-centric drug development, advancements in personalized medicine, regulatory backing for orphan drugs, and a rise in R&D investment.

The pharmaceutical formulation market is projected to witness robust expansion in the coming years, with its market size poised to reach $2948.64 billion by 2029, registering a compound annual growth rate (CAGR) of 9.3%. The acceleration during the forecast period can be linked to the breakthroughs in 3D printing technology, emphasis on pediatric drug formulations, biological mechanisms of drug delivery, the application of green chemistry in drug formulation, and the incorporation of artificial intelligence (AI). Notable trends that will prevail during this forecast span include an ascending dominance of biopharmaceuticals and biologics, refined systems of drug delivery, an increasing focus on personalized medicine and targeted formulations, the utilization of nanotechnology, along with strategized lifecycle management and reformation tactics.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9900

What Are the Current Market Growth and Trends in theDrug Formulation Market That Industry Players Should Watch?

The surge in technological innovations is becoming a growing trend in the realm of drug formulation. Larger companies within this industry are shifting their focus towards the development and incorporation of cutting-edge technologies to solidify their market standing. For instance, in June 2022, the American pharmaceutical company, Merck & Co., Inc., unveiled their Merck Digital Sciences Studio (MDSS). This innovation allows for the generation of state-of-the-art technologies for pharmaceutical research and development. By utilizing Azure Cloud’s potent computing and combining it with insight from Merck’s discovery and clinical experts, the introduction and fast tracking of new, groundbreaking digital technologies is ensured. The MDSS is a joint venture between Merck and the New Jersey Innovation Institute (NJII), which is owned by the New Jersey Institute of Technology. The project is funded by the Merck Global Health Innovation Fund, Northpond Ventures, and McKesson Ventures, with Microsoft offering technological assistance to start-up companies.

What Are the Major Market Players Making an Impact on theDrug Formulation Market Growth?

Major companies operating in the drug formulation market include AstraZeneca PLC, The Bristol-Myers Squibb Company, Eli Lilly and Company, Gilead Sciences Inc., Merck & Co. Inc., Novartis AG, Pfizer Inc., AbbVie Inc., C.H. Boehringer Sohn AG & Co. KG, F. Hoffmann-La Roche AG, Johnson & Johnson, Bayer AG, Teva Pharmaceutical Industries Ltd., Sanofi S.A., GlaxoSmithKline plc, Novo Nordisk A/S, Amgen Inc., Viatris Inc., Sandoz International GmbH, Takeda Pharmaceutical Company Limited, Sun Pharmaceutical Industries Ltd., Dr. Reddy’s Laboratories Ltd., Cipla Ltd., Lupin Limited, Torrent Pharmaceuticals Limited, Jubilant Life Sciences Limited, Cadila Healthcare Limited, Glenmark Pharmaceuticals Ltd., Wockhardt Ltd., Hikma Pharmaceuticals plc

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/drug-formulation-global-market-report

How Are the Key Segments of the Drug Formulation Market Driving Opportunities and Innovations?

The drug formulation market covered in this report is segmented –

1) By Dosage Form: Oral formulations, Parenteral Formulations, Topical Formulations, Inhalation Formulations

2) By Formulation: Tablets, Capsules, Injectable, Sprays, Suspensions, Powders, Other Formulations

3) By Therapy Area: Cardiovascular Diseases (CVDs), Pain, Diabetes, Cancer, Respiratory Diseases, Other Diseases

4) By End-User: Big Pharma, Small And Medium Pharma, Biotech Companies

Subsegments:

1) By Oral Formulations: Tablets, Capsules, Powders, Liquids Or Solutions

2) By Parenteral Formulations: Injectables, Implants, Infusions

3) By Topical Formulations: Creams, Ointments, Gels, Transdermal Patches

4) By Inhalation Formulations: Metered-Dose Inhalers (MDIs), Dry Powder Inhalers (DPIs), Nebulizers

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=9900&type=smpGlobal Drug Formulation Market, Global Drug Formulation Market Report, Global Drug Formulation Market Trends, Global Drug Formulation Market Size

Browse Through More Reports Similar to the Gobal Drug Formulation Maret 2025, By The Business Research Company:

Drugs For Benign Prostatic hypertrophy Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/drugs-for-benign-prostatic-hypertrophy-global-market-report

Drug Delivery Devices Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/drug-delivery-devices-global-market-report

Drug Discovery Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/drug-discovery-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How has the drug formulation market size evolved in recent years?

There has been a significant expansion in the drug formulation market in recent years. Its worth is estimated to increase from $1908.89 billion in 2024 to $2064.68 billion in 2025, with a compound annual growth rate (CAGR) of 8.2%. Factors such as biopharmaceutical advancements, patient-oriented drug creation, customized medication, regulatory backing for uncommon drugs, and increased investment in research and development have significantly contributed to the growth experienced in the historic period.

What are the predictions for the drug formulation market size in the coming years?

In the coming years, we can anticipate a solid expansion in the drug formulation market. It is projected to escalate to a market size of $2948.64 billion in 2029 with a Compound Annual Growth Rate (CAGR) of 9.3%. This expected growth over the forecast period can be credited to enhancements in 3d printing technology, emphasis on pediatric formulations, biological drug delivery systems, and the utilization of green chemistry in drug formulation, coupled with the incorporation of artificial intelligence (AI). Dominance of biopharmaceuticals and biologics, advanced drug delivery systems, personalized medicine and individualized formulations, implementation of nanotechnology, lifecycle management, and reformulation strategies are projected to be the main trends over the forecast period.

Get your drug formulation market report here!

https://www.thebusinessresearchcompany.com/report/drug-formulation-global-market-report

What key factors are fueling the growth of the drug formulation market?

The surge in chronic disease cases is predicted to drive the expansion of the drug formulation industry. These chronic diseases, defined as conditions lasting for a year or longer that need consistent medical care, restrict daily life activities, or both, have the potential to be mitigated by drug formulation. Multiple drug delivery strategies are employed to maximize therapeutic effectiveness and minimize negative impacts. This is achieved by influencing how the medicine is absorbed, distributed, metabolized, and excreted. For example, the National Institutes of Health (NIH), an American biomedical research institution, released a report in September 2022 predicting that by 2023, the number of Americans aged 50 and older suffering from at least one chronic disease will increase by 99.5%. This implies a jump from 71.52 million in 2020 to 142.66 million in 2050. Furthermore, the number of people with multiple illnesses is expected to rise by 91.16% — from 7.8304 million in 2020 to 14.968 million in 2050. Thus, the increasing incidence of chronic diseases is fueling the growth of the drug formulation industry.

How is the global drug formulation market divided into key segments?

The drug formulation market covered in this report is segmented –

1) By Dosage Form: Oral formulations, Parenteral Formulations, Topical Formulations, Inhalation Formulations

2) By Formulation: Tablets, Capsules, Injectable, Sprays, Suspensions, Powders, Other Formulations

3) By Therapy Area: Cardiovascular Diseases (CVDs), Pain, Diabetes, Cancer, Respiratory Diseases, Other Diseases

4) By End-User: Big Pharma, Small And Medium Pharma, Biotech Companies

Subsegments:

1) By Oral Formulations: Tablets, Capsules, Powders, Liquids Or Solutions

2) By Parenteral Formulations: Injectables, Implants, Infusions

3) By Topical Formulations: Creams, Ointments, Gels, Transdermal Patches

4) By Inhalation Formulations: Metered-Dose Inhalers (MDIs), Dry Powder Inhalers (DPIs), Nebulizers

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9900&type=smp

Who are the key firms paving the way for growth in the drug formulation market?

Major companies operating in the drug formulation market include AstraZeneca PLC, The Bristol-Myers Squibb Company, Eli Lilly and Company, Gilead Sciences Inc., Merck & Co. Inc., Novartis AG, Pfizer Inc., AbbVie Inc., C.H. Boehringer Sohn AG & Co. KG, F. Hoffmann-La Roche AG, Johnson & Johnson, Bayer AG, Teva Pharmaceutical Industries Ltd., Sanofi S.A., GlaxoSmithKline plc, Novo Nordisk A/S, Amgen Inc., Viatris Inc., Sandoz International GmbH, Takeda Pharmaceutical Company Limited, Sun Pharmaceutical Industries Ltd., Dr. Reddy’s Laboratories Ltd., Cipla Ltd., Lupin Limited, Torrent Pharmaceuticals Limited, Jubilant Life Sciences Limited, Cadila Healthcare Limited, Glenmark Pharmaceuticals Ltd., Wockhardt Ltd., Hikma Pharmaceuticals plc

Which trends are expected to transform the drug formulation market?

The emergence of novel technologies is a significant trend in the drug formulation market that is gaining traction. To consolidate their market position, leading players in this domain are focusing on launching breakthrough technologies. For instance, Merck & Co., Inc., an American pharmaceutical firm, launched the Merck Digital Sciences Studio (MDSS) in June 2022. This project was designed to bring forth innovative technologies for drug research and development using Azure Cloud’s robust computing and Merck’s expert team of clinical and discovery specialists. The MDSS represents a collaborative effort between Merck and the New Jersey Innovation Institute (NJII), an entity owned by the New Jersey Institute of Technology. This venture has received financial backing from the Merck Global Health Innovation Fund, Northpond Ventures, and McKesson Ventures while tech support for start-ups will be provided by Microsoft.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9900

What regions are contributing significantly to the growth of the drug formulation market?

North America was the largest region in the drug formulation market in 2024. Asia-Pacific is expected to be the fastest-growing region in the drug formulation market report during the forecast period. The regions covered in the drug formulation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Browse Through More Similar Reports By The Business Research Company:

Drugs For Benign Prostatic hypertrophy Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/drugs-for-benign-prostatic-hypertrophy-global-market-report

Drug Delivery Devices Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/drug-delivery-devices-global-market-report

Drug Discovery Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/drug-discovery-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How Will the Drug Formulation Market Grow Over the Forecast Period Based on Its Expected CAGR?

The market size for drug formulation has seen robust growth in the past few years. From a size of $1908.89 billion in 2024, it’s projected to rise to $2064.68 billion in 2025, boasting a compound annual growth rate (CAGR) of 8.2%. Factors like biopharmaceutical innovation, the concept of patient-centric drug development, the rise of personalized medicine, regulatory encouragement for orphan drugs, and elevated investment in research and development have contributed greatly to the historical growth of this market.

It is predicted that the drug formulation market will witness robust expansion over the next few years, reaching an estimated $2948.64 billion by 2029, with a compound annual growth rate (CAGR) of 9.3%. This predicted surge during the forecast period is due to various factors including the emergence of 3D printing, emphasis on pediatric formulations, the development of biological drug delivery systems, the adoption of green chemistry in formulation, and the incorporation of artificial intelligence (AI) in the process. Pertinent trends expected during the forecast period include the dominance of biopharmaceuticals and biologics, the evolution of advanced drug delivery systems, the advent of personalized medicine and individualized formulations, the integration of nanotechnology, and the strategies revolving around lifecycle management and reformulation.

What Major Innovations Are Driving the Accelerated Growth of the drug formulation Market?

The surge in chronic diseases is anticipated to drive the expansion of the drug formulation market. Chronic diseases are described as conditions that persist for a year or more and necessitate continual medical care, restrict everyday activities, or both. Drug formulation can help decrease the incidence of chronic diseases by making use of various drug delivery techniques to enhance therapeutic efficacy and reduce negative side effects via influencing medication absorption, distribution, metabolism, and excretion. As an example, a report by the National Institutes of Health (NIH), a US-based biomedical research agency, in September 2022 detailed that the population of individuals in the United States aged 50 and above suffering from at least one chronic disease is expected to grow by 99.5%, from 71.52 million in 2020 to 142.66 million in 2050. Likewise, individuals dealing with multimorbidity is set to increase by 91.16% from 7.8304 million in 2020 to 14.968 million in 2050. Consequently, the severity and spread of chronic diseases are promoting the expansion of the drug formulation market.

Get Your Free Sample of the Global Drug Formulation Market Report Now!

https://www.thebusinessresearchcompany.com/sample.aspx?id=9900&type=smp

Who Are the Leading Companies Pioneering Change in the Drug Formulation Market?

Major companies operating in the drug formulation market include:

• AstraZeneca PLC_x000D_

• The Bristol-Myers Squibb Company_x000D_

• Eli Lilly and Company_x000D_

• Gilead Sciences Inc._x000D_

• Merck & Co. Inc._x000D_

What Are the Most Significant Trends Transforming the Drug Formulation Market Today?

Advances in technology are becoming an increasingly important trend in the drug formulation industry. To solidify their market standing, major market players are focusing on integrating new and advanced technologies. An example of this is the June 2022 launch of Merck Digital Sciences Studio (MDSS) by the US pharmaceutical firm, Merck & Co., Inc. This platform aims to foster the development of innovative drug research and development technologies, utilizing the high-performance computing of Azure Cloud and the expertise of Merck’s discovery and clinical teams. The initiative is a joint venture between Merck and the New Jersey Innovation Institute (NJII), an entity under the purview of the New Jersey Institute of Technology. Financial backing for the project comes from the Merck Global Health Innovation Fund, Northpond Ventures, and McKesson Ventures, with Microsoft offering technological assistance to start-up companies.

Get Instant Access to the Global Drug Formulation Market Report with Swift Delivery!

https://www.thebusinessresearchcompany.com/report/drug-formulation-global-market-report

What Are the Core Categories and Segments in the Drug Formulation Market Driving Demand and Growth?

The drug formulation market covered in this report is segmented –

1) By Dosage Form: Oral formulations, Parenteral Formulations, Topical Formulations, Inhalation Formulations

2) By Formulation: Tablets, Capsules, Injectable, Sprays, Suspensions, Powders, Other Formulations

3) By Therapy Area: Cardiovascular Diseases (CVDs), Pain, Diabetes, Cancer, Respiratory Diseases, Other Diseases

4) By End-User: Big Pharma, Small And Medium Pharma, Biotech Companies

Subsegments:

1) By Oral Formulations: Tablets, Capsules, Powders, Liquids Or Solutions

2) By Parenteral Formulations: Injectables, Implants, Infusions

3) By Topical Formulations: Creams, Ointments, Gels, Transdermal Patches

4) By Inhalation Formulations: Metered-Dose Inhalers (MDIs), Dry Powder Inhalers (DPIs), Nebulizers

Which Regions Are Leading the Charge in Drug Formulation Market Development?

North America was the largest region in the drug formulation market in 2024. Asia-Pacific is expected to be the fastest-growing region in the drug formulation market report during the forecast period. The regions covered in the drug formulation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

What Key Elements Shape the Definition of the Drug Formulation Market?

Drug formulation is defined as the process of combining several chemical and biological ingredients, including the active medicine, to create a finished pharmaceutical product. It is used to be modify and optimize the drugs during the preclinical stage and initial research.

Browse Through More Similar Reports By The Business Research Company:

Drugs For Benign Prostatic hypertrophy Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/drugs-for-benign-prostatic-hypertrophy-global-market-report

Drug Delivery Devices Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/drug-delivery-devices-global-market-report

Drug Discovery Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/drug-discovery-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: